Latest Aortic valve stenosis Stories
Catheter-delivered aortic valve durable at 3 years All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session. The transcatheter aortic valve replacement (TAVR) system was investigated as an alternative to...
Even though young athletes are required to receive health screens to be cleared to play sports, those tests failed to detect important cardiovascular abnormalities in cleared players, and many were allowed to play despite suspicions of dangerous cardiovascular conditions, according to a large registry study of patients who died from sudden death, being presented March 10 by Kevin Harris, MD, research cardiologist at the Minneapolis Heart Institute Foundation (MHIF). The data is being...
Researchers have discovered a gene associated with a form of cholesterol that increases the risk of developing aortic stenosis, the most common form of heart valve disease, by more than half. This international study, involving the Research Institute of the McGill University Health Centre (RI-MUHC), is the first of its kind to uncover a genetic link with aortic valve disease – a condition that affects more than 5 million people in North America. The results of the study, published in the...
Study described in the New England Journal of Medicine is the first to show cause-and-effect relationship between a gene variant and calcium deposits on the aortic valve Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis. The study is the first large-scale, genome-wide association...
Results of PARTNER Cohort B trial presented at TCT 2012 A study found that transcatheter aortic valve replacement (TAVR) yielded lower mortality rates after three years compared with medical therapy in patients deemed to be ineligible for conventional aortic valve surgery. Results of the PARTNER Cohort B trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the...
NATICK, Mass., Oct. 10, 2012 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus(TM) Valve System in up to 120 patients with severe aortic valve disease. This international, multi-center study includes 15 sites in Australia, France, Germany and the United Kingdom. The Lotus Valve System is the first transcatheter aortic valve replacement (TAVR) device of its kind that is...
Transcatheter aortic valve implantation (TAVI) leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis that are maintained for at least 1 year, according to a study presented at ESC Congress 2012. The results from the German transcatheter aortic valve interventions registry were presented by Professor Till Neumann, MD, from Essen, Germany. Aortic stenosis is the most common valvular heart disease with increasing incidence especially with...
Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI. The findings were presented at ESC Congress 2012 by Professor Karin Humphries from St. Paul's Hospital. More than 1.5 million people in the US suffer from aortic stenosis, a progressive disease where the aortic valve becomes obstructed, leading to life-threatening...
Two Local Seniors Share Their Story CINCINNATI, June 26, 2012 /PRNewswire-USNewswire/ -- Nearly one in every eight Americans aged 75 and older will be diagnosed with valvular heart disease. Many of these patients suffer from a severe form of valve disease that requires their diseased aortic valve to be replaced. Transcatheter aortic valve replacement (TAVR) has been studied in clinical trials for patients whose heart valves need replacing, but are at increased risk for...
NEWARK, Del., May 17, 2012 /PRNewswire-USNewswire/ -- Research led by Christiana Care Health System's Andrew Doorey, M.D. has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography. (Photo - http://photos.prnewswire.com/prnh/20120517/DC09321) (Logo - http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) The findings - presented May 10 in in Las Vegas during the Society for Cardiovascular Angiography and Interventions' annual...
